Tricerion is pleased to announce a follow-on Innovate UK grant to commercialise its digital vaccination passport. Thank you to Innovate UK and our wonderful monitoring officer Ebela Howell.

ImmucheX is Tricerion’s digital immunity App and will allow an individual to prove immunity via vaccination, using a privacy first design; the ImmucheX portal allows for secure access for vaccine records, to be accessed by healthcare professionals only with an audit trail.

Schehrezade Davidson, CEO, Tricerion, said “We are proud to have this validation for the ImmucheX strategy. We look forward to the potential of commercialising the solution with governments across the world.”